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Abstract: The consumption of tea originated in ancient China over 4000 years ago and is 
currently the second most popular beverage in the world after water. Tea is an aromatic 
beverage prepared by pouring hot water over cured leaves of the Camellia sinensis plant. 
The link between tea intake, most notably green tea, and health has resulted in intense 
research on the components responsible for preventing the onset of several chronic diseases, 
including atherosclerosis, cancer, obesity and diabetes. In particular, the high levels of 
chemically diverse phenols (e.g., phenolic acids, flavonoids) present in tea exhibit potent 
protective properties against many of these diseases. Although health related research on 
green tea and its predominant phenol (catechins) has been on-going for decades, major 
advances have occurred in the last 5–10 years. Therefore, this review focuses on seminal 
studies reported primarily within the last five years but not extending past ten years on the 
link between health and green tea with an emphasis on the catechins.  
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1. Introduction 
Tea originated in China over 4000 years ago and has since been a popular luxury commodity by 
the Asian population valued for its taste, aroma, medicinal applications, and cultural history [1]. The 
golden age of tea occurred during the Tang Dynasty (A.D. 618–906) as cultivation and trading routes 
expanded outside of China. The tea rules and ceremony developed by Lu Yu (733–804) as described in 
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Cha Chang or The Classic of Tea led to the earliest treatise on tea. Steaming of the leaves became the 
normal custom along with specific guidelines for processing the leaves and brewing the beverage. Lu 
Yu’s work transformed the process into an art form and set the standard for tea cultivation/production 
in China. This ceremony eventually became the model that would emerge in Japan [2,3]. Tea arrived in 
Japan and Korea during the 6th century resulting in another highly sustainable market. Tea was 
subsequently introduced to Indonesia and India and then followed the trade routes into Europe (~1610), 
most notably Holland and England. At this point in world history, tea was considered such a high 
valued commodity that it was used for currency and international trade [2,3]. Tea is now cultivated in 
more than sixty countries with Asia (China, India, Japan, Sri Lanka, and Taiwan) producing more than 
91% of the total amount annually (Table 1) [4]. While fermentation has aided in the ease of exporting 
tea and is a principal factor for the West’s preference for black tea, green tea, or unfermented tea, is 
preferred in the East. However, tea drinking in North America and the Middle East of any kind is still 
comparatively low relative to China, Japan, and other European countries.  
Table 1. Average annual tea production quantities by country (2005 to 2010).  
Country Quantities (tons) 
China 1,217,039 
India 963,313 
Kenya 344,596 
Sri Lanka 304,036 
Turkey 209,535 
Viet Nam 167,531 
Indonesia 154,328 
Iran 108,751 
Japan 92,233 
Argentina 76,071 
Thailand 59,203 
Bangladesh 58,763 
Malawi 46,155 
Uganda 41,543 
United Republic of Tanzania 31,850 
Data from FAO database (http://faostat3.fao.org/home/index.html [5]).  
Green tea (GT) is made from the leaf of Camellia sinensis and is typically cultivated in hot humid 
climates [4]. Harvesting of high quality GT can simply be described as “two leaves and a bud” plucked 
from every new shoot. The process of GT production (Figure 1) preserves many compounds that have 
been linked to multiple human health properties making GT stand out from fermented black and  
semi-fermented oolong tea. As such, GT and its extracts have been used to enrich energy drinks, juices, 
vitamins, and other food systems. Of the health benefiting agents present in GT, the catechins have 
received major research focus [6,7]. Therefore, instead of attempting to summarize the wealth of 
literature published in this area, seminal studies reported primarily from the last five years but not 
extending past ten years will be reviewed with an emphasis on the GT catechins. 
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Figure 1. Tea production and its influence on the final polyphenols content (adapted from 
Cabrera et al. [8]). 
 
2. Composition of Green Tea 
Green tea is a rich source of health promoting components (nutraceuticals or bioactives) largely due 
to its high levels of chemically diverse phenolic compounds, which account for ~30% and 50% of the 
GT leaf and beverage on a dry weight basis, respectively (Figure 2).  
Figure 2. Principal components of green tea leaf and green tea beverages (adapted from 
Balentine et al. [9]).  
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Flavan-3-ols are the major class of GT flavonoids with the catechins being the predominant  
form [9], including (−)-epicatechin (EC), (−)-epicatechin gallate (ECG), (−)-epigallocatechin (EGC) 
and (−)-epigallocatechin gallate (EGCG) (Figure 3). Among these compounds, EGCG represents  
~59% of the total catechins [8]. Green tea also contains the phenolic acids, gallic acid, chlorogenic 
acid and caffeic acid, and the flavonols, kaempferol, myricetin, quercetin and their conjugates  
(Figure 2). Other flavonoids that account for a very small fraction of the tea have more recently  
been identified and include 19 O-glycosylated flavonols, 7 C-glycosylated flavones, 28 acylated 
glycosylated flavonols and 3 flavonols [10]. While not the focus of this review, it must be noted that 
the fat soluble compounds present in GT, such as vitamin E and the carotenoids (2% dry weight) may 
work with the phenols to enhance health benefits [8] albeit limited studies have been reported on 
possible synergistic effects. Additionally, GT contains linoleic and linolenic acids (7% dry weight) [9], 
which are only detected at trace levels after infusion as these compounds are involved in synthesizing 
the essential oils that contribute to the “green odor” [11]. Monosaccharide and water-soluble 
polysaccharides comprise nearly 20% of the GT leaf and are also compounds of interest due to their 
links to health [9]. Lastly, polysaccharide conjugates have been isolated but their structures vary 
depending on the origin of the tea [12,13].  
Figure 3. Structure of major green tea flavonoids. 
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3. Oxidative Stress  
Reactive oxygen species (ROS), such as the hydroxyl radical (OH), superoxide (O2−) and hydrogen 
peroxide (H2O2), maintain cellular homeostasis by acting as cell signaling agents or by regulating gene 
expression [14,15]. If left unchecked however ROS imbalances can cause cellular oxidative  
stress that can lead to chronic conditions and diseases, e.g., cancer, cardiovascular diseases and 
neurodegenerative diseases. Reports have shown that GT and its predominant phenols (in isolation) 
prevent or remediate oxidative stress via multiple mechanisms. A recent study by Schroeder et al. [16] 
showed that the most abundant GT catechin (EGCG) protected the neuron by lowering levels of 
mitochondrial free radicals and preventing apoptosis induced by oxidative stress. Guo et al. [17] 
demonstrated that GT catechins fed to a 6-OHDA rat model presented with reduced levels of inducible 
nitric oxide (NO) synthase and protein-bound 3-nitro-tyrosine. GT catechins also prevented ROS and 
NO generation, lipid peroxidation and increased nitrite/nitrate ratio in a dose dependent manner. GT 
polyphenols also play a role in reducing cellular levels of ROS generating redox-active metals. 
Quesada et al. [18] determined that EGCG binds to zinc cations with high affinity thereby reducing the 
accumulation of zinc in a human liver hepatocellular carcinoma (HepG2) cell model. Another study 
reported by Wei and Meng [19] showed that EGCG reversed lead-induced oxidative damage in 
ventricular myocytes isolated from rat hearts and reduced OH, O2−, and H2O2 levels. 
By acting as a pro-oxidant, GT has often been linked to the apoptotic induction of tumor cells [20]. 
Oxidative stress induced by GT polyphenols may also trigger endogenous antioxidant systems in 
normal tissues. Maeta et al. [21] showed that 0.1% GT extract or 0.05% (1.1 mM) EGCG  
produced H2O2 in yeast models grown in weak alkaline medium. Nuclear localization of  
oxidative-stress-responsive transcription factors (Yap1 and Msn2 in S. cerevisiae, and Pap1 in  
S. pombe) were subsequently activated. Elbling et al. [22] reported the autoxidation of EGCG resulted 
in low-doses of H2O2, reduced DNA damage and cytotoxicity in keratinocyte-derived HaCat cell. 
Additionally, these low levels of H2O2 initiated the up-regulation of antioxidant enzymes and lowered 
ROS levels. The antioxidant and pro-oxidant effects of GT polyphenols may be linked to other health 
benefits discussed in subsequent sections. A summary of this information and associated references are 
provided in Table 2.  
4. Inflammation 
Inflammation is the body’s way of dealing with localized tissue damage/infection and is thus critical 
to our survival. Yet, low grade but continued stimulation of the inflammatory response can lead to 
chronic inflammation, which can then progress to coronary heart diseases, Alzheimer’s disease, type 2 
diabetes, muscle degeneration, and cancer [23–25]. Many reports have shown the anti-inflammatory 
properties of GT but the mechanisms eliciting the response vary between the studies.  
Neutrophils are triggered at a specific site in the body by infections, tissue necrosis, necrotic cells, 
foreign bodies-dirt, and immune signals, including those of chronic inflammation thereby contributing 
to the inflammatory cycle. Dona et al. [26] reported that EGCG not only inhibited neutrophil elastase 
in an in vitro model but also down-modulated ROS activity, caspase-3 activity, DNA fragmentation, 
and the ability of neutrophiles to migrate towards a chemotactic stimulus. The in vivo part of this study 
showed that EGCG inhibited neutrophil recruitment, inflammation-driven angiogenesis, and 
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pulmonary fibrosis. Yet another in vivo study completed by Shen et al. [27] demonstrated that  
fibrosis in female rats caused by chronic inflammation was significantly reduced when treated with  
GT catechins.  
Table 2. Recent studies on green tea and oxidative stress.  
References Model Treatment Dosage Main outcomes 
Schroeder et al. 
[16] 
Rat cerebellar granule 
neurons cultures 
EGCG  
5, 10, or  
20 μM 
90%–95% of 3H-EGCG 
accumulated in mitochondria. 
EGCG treatments resulted in 
reduced levels of free radicals and 
protected neuron from apoptosis 
induced by oxidative stress. 
Guo et al. 
[17] 
6-hydroxydopamine 
(6-OHDA)-treated rat 
model of Parkinson’s 
Disease 
GTP (98% 
purity) 
containing 50% 
EGCG, 22% 
ECG, 18% EGC 
and 10% EC 
150, 450 
mg/kg/ 
day-fed 
GTP treatment dose-dependently 
decreased ROS and NO level, 
lipid peroxidation, nitrite/nitrate 
ratio, and expression of inducible 
nitric oxide synthase and  
protein-bound 3-nitro-tyrosine. 
Quesada et al. 
[18] 
Human HepG2 cells EGCG 10 μM 
EGCG binded to zinc cations with 
high affinity and thus reduced the 
accumulation of zinc. 
Wei & Meng 
[19] 
Myocytes from the 
hearts of adult rats 
EGCG 0–60 μg/mL 
Formation of OH−, O2−, and H2O2 
was decreased significantly as 
EGCG concentration increased 
compared to lead treated group. 
Maeta et al. 
[21] 
Budding yeast S. 
cerevisiae and fission 
yeast S. pombe 
EGCG and GTE 
0.05% 
EGCG 
0.1% GTE 
H2O2 produced by EGCG and 
GTE induced the expression of 
nuclear localization of  
oxidative-stress-responsive 
transcription factors (Yap1 and 
Msn2 in S. cerevisiae, and Pap1 in 
S. pombe). 
Elbling et al. 
[22] 
Human keratinocytes EGCG 0–100 μM 
Low-dose H2O2 and EGCG 
treatment enhanced the clearance 
of ROS and reduced DNA  
damage and cytotoxicity in 
keratinocyte-derived HaCat cell.  
EGCG: (−)-epigallocatechin gallate; ECG: (−)-epicatechin gallate; EGC: (−)-epigallocatechin;  
EC: (−)-epicatechin; GTP: green tea polyphenols; ROS: reactive oxygen species; NO: nitric oxide;  
GTE: green tea extract; HaCAT: human keratinocyte line.  
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Regulatory T cells (T-reg) are essential in maintaining immune functions by targeting sites of 
sustained inflammation [28]. Recent in vitro and in vivo studies showed that EGCG (2–50 μM) 
induced T-reg via the up-regulation of Foxp3, i.e., a transcription factor regulated by DNA  
methylation [29]. The effect of EGCG on Foxp3 gene expression was similar to that of DNA 
methyltransferase inhibitors. EGCG also inhibited nuclear factor-kappa B (NF-κB)-mediated 
inflammatory responses in mice models via the Nrf2 antioxidant signaling pathway by increasing 
systemic T-reg cell activity [30]. Wu et al. [31] investigated the ability of EGCG to suppress 
proliferation of T-reg in the spleen of C57BL mice. The results indicated that 2.5 to 10 μM EGCG 
inhibited T-reg proliferation but did not induce apoptosis or increase oxidative stress. These 
researchers identified that the EGCG modulated pathway was related to IL-2/IL-2 receptor signaling. 
Other mechanisms involving the inhibition of immune related cell signaling in response to  
GT-polyphenols have been reported. Ranjith-Kumar et al. [32] showed that GT-EGCG can bind to the 
retinoic acid inducible gene I (RIG-I) and thus interfere with interferon signaling response in 
mammalian HEK293T cells. Moreover, this polyphenol was able to suppress ATPase activity of 
recombinant RIG-I without competing with RIG-I and RNA or ATP. Analysis of the structure-activity 
relationship of commercially available analogs revealed that RIG-I inhibitors included epimers 
gallocatechin gallate and theaflavin 3,3’ digallate. EGCG was also shown to down regulate gene 
expression related to macrophage migration. Using human keratinocytes, Noh and Park [33] reported 
down regulation of the dexamethasone-induced macrophage migration inhibitory factor (MIF) in the 
presence of EGCG and the expression of MIF-induced cytokines and chemokines, such as interleukin 
(IL)-6, IL-18, transforming growth factor-β, CCL17, CCL22 and CXCL10, were subsequently 
inhibited. Ripley et al. [34] reported that EGCG up-regulated STAT5 transcription factor and induced 
the suppressor of cytokine signaling 1 gene through the superoxide pathway. These studies are 
itemized in Table 3.  
5. Cardiovascular Health 
Studies have also increased on GT intake and the promotion of cardiovascular health [35,36].  
Qin et al. [37] showed that GT polyphenols can alter the mRNA expression of the cardiac insulin 
signaling pathway, regulate cardiac mRNA expression of cardiac lipid metabolism, and regulate the 
inflammation-related gene expression in insulin resistant rats fed a high-fructose diet. These results 
indicate the potential ability of GT to reduce the risk of coronary artery disease. Another study by 
Lorenz et al. [38] compared stimulus NO production and vasodilation in response to GT and black tea 
exposure. In the presence of the GT catechins, eNOS activity and vasorelaxation were induced by 
activating and phosphorylating the signaling kinases in endothelial cells. Similar results were obtained 
with black tea indicating that the theaflavins and thearubigins may be the responsible components.  
El Bedoui et al. [39] also showed that EGCG inhibited matrix metalloproteinase-2 activity and thus 
prevented vascular smooth muscle cell invasion. 
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Table 3. Recent studies on green tea and inflammation. 
References Model Treatment Dosage Main Outcomes 
Dona et al. 
[26] 
Neutrophils and 
C57 black mice 
EG CG 1–100 μM 
EGCG down-modulated ROS activity, 
and inhibited apoptosis and chemotaxis 
in vitro model. EGCG also inhibited 
neutrophil recruitment, angiogenesis and 
pulmonary fibrosis. 
Shen et al. [27] 
3-month-old 
female rats 
GTP (98.5% 
purity) 
0.5% in 
water 
The development of fibrosis in vessels 
and myocardium in rat decreased 
significantly with supplementation  
via down-regulation of TNF-α  
mRNA expression. 
Wong et al. [29] 
Human Jurkat 
leukemic CD4+ T 
cell line and 
eight-week old 
Balb/c male mice 
EGCG 
GT 
beverage 
2, 10, 50 
μM 
2%, w/v 
EGCG induced expression of Foxp3 and 
increased T-reg frequencies and 
numbers both in vitro and in vivo. 
Tsai et al. [30] 
1 2-weeks-old 
female NZB/W 
F1 mice 
EGCG 
120 mg/kg 
body weight 
T-reg activity increased in EGCG 
treated mice. 
Wu et al. [31] 
C57BL mice 
spleen cells 
EGCG 2.5–10 μM 
EGCG targeted the pathway which is 
related to IL-2/IL-2 receptor signaling 
and inhibited T cell proliferation. 
Ranjith-Kumar  
et al. [32] 
Human 
HEK293T cells 
EGCG 0–10 μM 
EGCG inhibited RIG-I by binding to 
RIG-I and suppressing ATPase activity 
of recombinant RIG-I. 
Noh and Park 
[33] 
Human 
keratinocytes 
EGCG 100 μmol/L 
EGCG down regulated MIF mRNA 
expression and MIF induced cytokines 
and chemokines. 
Ripley et al. [34] 
Monocytes of 
human PBMCs 
and SOC1-
deficient 
C57BL/6 mice 
GTE and 
EGCG 
0–200 μM 
EGCG inhibited cytokine signaling  
1 gene expression via inducing the 
SOC1 expression and un-regulating 
STAT5 transcription factor.  
EGCG: (−)-epigallocatechin gallate; GTP: green tea polyphenols; TNF-α: tumor necrosis factor alpha;  
GT: green tea; IL-2: interleukin 2;  RIG-I:  retinoid-inducible gene 1; MIF: migration inhibitory factor; 
PBMCs:  peripheral blood mononuclear cells, GTE: green tea extract. 
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Other studies have shown that GT polyphenols may function by modulating cholesterol metabolism. 
Bursill and Roach [40] reported decreased cholesterol synthesis in HepG2 cells when incubated with 
50 μM of GT-EGCG. However, cholesterol synthesis increased significantly using 200 μM of  
GT-EGCG while cellular cholesterol remained at a low level. In the latter case, 30% more cholesterol 
was detected in medium indicating that higher EGCG concentrations promoted the efflux of 
cholesterol. Although the researchers used other GT catechins, GCG was the only catechin capable of 
up regulating low-density lipoprotein (LDL) receptor activity [40]. Up-regulation of LDL receptor also 
occurred in GT-polyphenolic fed cholesterol-fed rabbits [41]. Six experimental rabbits fed a 0.25% 
(w/w) cholesterol diet for two weeks followed by catechin enriched diets supplemented of 0, 0.5, 1 or 
2% (w/w) for four weeks showed up-regulation of LDL receptor activity and a 60% reduction in 
plasma cholesterol (80% in LDL cholesterol). 
Multiple human clinical studies have been completed to determine the anti-arthrosclerosis benefits 
of GT consumption. In one study [42], 14 healthy individuals at an average age of 30 years were 
separated into three groups. Each group consumed one of 450 ml of 6 g GT (brewed Lipton tea),  
250 mg caffeine (amount contained in GT) or water. Flow-mediated dilatation (FMD) of the brachial 
artery was then measured at 30, 90, 120 min intervals. FMD significantly increased in the GT group 
but were similar in both the caffeine and water control groups suggesting possible benefits of GT on 
coronary endothelial function. Zheng et al. [43] identified and quantified the possible effects of a GT 
beverage versus a GT extract on human cholesterol profiles by performing a meta-analysis of  
14 randomized trials reported in the literature. The researchers concluded that GT consumption had no 
significant effect on high density lipoprotein cholesterol in fasting serum but significantly reduced total 
cholesterol levels by 7.20 mg/dL and significantly decreased the LDL-cholesterol concentration by 
2.19 mg/dL. In reviews by Deka and Vita [35] and Del Rio et al. [36], other epidemiological data 
providing evidence for and against GT and cardiovascular health connection are summarized. 
6. Obesity and Diabetes 
Metabolic syndrome is a multifaceted condition characterized by elevated waist circumference, 
dysglycemia, elevated blood pressure, decreased serum high-density lipoprotein-associated cholesterol, 
and increased serum triglycerides, i.e., risk factors for diabetes and cardiovascular disease. As 
metabolic cases are increasing at an unprecedented rate in the US and throughout other western 
countries, there is considerable interest in the potential benefit of tea consumption for prevention of 
metabolic syndrome [44]. Numerous in vitro studies and animal models have shown beneficial effects 
of GT catechins on several of these risk factors, including reduced body fat, improved glucose 
tolerance and maintenance of a healthy cardiovascular system. As studies specific to GT and 
cardiovascular health have been discussed in the previous section, select obesity and diabetes related 
research will be presented in this section.  
Several studies using animal models investigated the possible relationships between GT phenols 
and the development of obesity and other related disease risk factors. Bose et al. [45] reported that 
three month old obese mice fed a high fat (HF) diet but supplemented with EGCG not only attenuated 
the development of metabolic syndrome but also reversed the symptoms. Body weight, body fat, blood 
glucose, plasma insulin, plasma cholesterol, inflammatory markers and liver fat were all significantly 
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lower in 16 weeks for the mice fed the HF diet + EGCG compared to the control. After receiving a  
3.2 g/kg EGCG supplemented diet, the visceral fat weight in the mice decreased 36% in nine weeks 
and blood glucose level decreased 22% in four weeks [45]. Sae-tan [46] showed that C57bl/6J mice 
fed a HF diet that included EGCG (0.32% dietary) for 16 weeks resulted in increased gene expression  
(1.4- to 1.9-fold) of several proteins involved in mitochondrial fatty acid oxidation, including nuclear 
respiratory factor 1, medium chain acyl coA decarboxylase, uncoupling protein 3, and peroxisome 
proliferator responsive element α. In addition, increased lipids in the fecal material of the mice  
were reported. Another proposed mechanism included modulation of fat lost via an EGCG link.  
Lee et al. [47] tested the hypothesis that EGCG promotes triacylglycerol hydrolysis by increasing gene 
expression of hormone sensitive lipase. In this study, lipid accumulation in 3T3-L1 adipocytes 
decreased significantly after a 24 h treatment with 10 μM EGCG while cell viability was retained. 
Richard et al. [48], used male-deficient (ob/ob) mice and their lean counterparts (mice C57BL/6J mice) 
to investigate whether regular decaffeinated green tea intake affected body weight and lipid profiles. 
GT consumption resulted in significantly lower weight gain in the obese mice and associated 
cholesterolemia, triglyceridemia, and adiponectin concentrations but did not adversely affect the  
lean model. 
Cao et al. [49] determined the possible molecular mechanistic connection between GT catechins 
using a high-fructose fed mice model. This study showed that 1–2 g of GT extracts influenced gene 
expression of several important regulators of glucose intake and insulin signal pathways. In a similar 
study, Hininger-Favier et al. [50] demonstrated the effects of GT extracts on insulin sensitivity using 
Wistar rats fed a high-fructose diet (FD) without or with 1 or 2 g of GT supplements for six weeks. 
The FD fed rats developed insulin resistance while rats fed GT supplements did not. Additionally, the 
rats fed the GT supplement presented with decreased levels of plasma lipid peroxidation, sulfhydryl 
group oxidation, and DNA oxidative damage. A recent study by Ma et al. [51] revealed tyrosine 
phosphatase (purified from E. coli) was inhibited in response to a GT extract. As a down regulator of 
both the insulin and leptin signaling pathways, inhibitors of tyrosine phosphatase are considered 
promising approaches to treat diabetes and obesity.  
Other studies using human subjects of Asian descent have shown the benefits of GT intake in terms 
of reducing risk factors for obesity and diabetes [52–54]. In particular, the Ohsaki study [54], which 
followed 40,530 Japanese adults (aged from 40 to 79) for 11 years, revealed a strong inverse 
association between GT consumption and cardiovascular disease mortality. Recently, researchers at the 
Oklahoma State University compared body weight, lipids and lipid peroxidation in 35 obese subjects 
provided either a product with or without a GT extractable [55]. These results supported the Ohsaki 
study again positively correlating GT intake with decreased body weight, body mass index and 
biomarkers for lipid peroxidation (malondialdehyde and hydroxynonenals).  
7. Cancer 
According to Khan and Mukhtar [56], 765 reports have been published showing the potential of 
GT polyphenols as cancer chemoprevention agents. Therefore, only a sample of those studies is 
provided in this section (also refer to Table 4). For example, Ohga et al. [57] studied GT-EGCG as a 
therapeutic treatment against several different cancer cell lines. While EGCG had no adverse effect on 
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normal endothelial cells, it did exert anti-angiogenic properties by selectively suppressing the 
migration of tumor-associated endothelial cells and endothelial progenitor cells. Kato et al. [58] 
studied the response of the RECK gene, a novel tumor suppressor gene, in oral squamous cell 
carcinoma cell lines (oral cancer cell) treated with EGCG. The hypermethylation status of the RECK 
gene was partially reversed by EGCG whereas the gene expression level of RECK mRNA was 
significantly enhanced. 
A recent in vitro study showed that GT-EGCG inhibited the growth of advanced prostate cancer by 
competitively binding to the androgen receptor (AR) and interrupting the gene expression regulated by 
AR [59]. EGCG acted at multiple levels including inhibiting interdomain N-C termini interaction, 
repressing the prostate cancer related mutant T877A and eventually inhibiting cancer cell growth.  
Lee et al. [60] obtained similar results using a prostate cancer cell line in response to GT catechins. 
The researchers proposed that catechins modulated AR acetylation was modulated in the presence of 
GT catechins thereby inhibiting the translocation of the AR protein to the nucleus. The activity was 
comparable to that exhibited by anti-histone acetyltransferase. 
Although the cited studies were conducted with experimental cell models, many others have 
included tissues collected from human clinic trials (animal and human). By using six tumor related 
genes in 106 gastric cancer patients, Yuasa et al. [61] showed that methylation of homeobox 
transcription factor and bone morphogenetic protein 2 were inversely correlated with GT intake. 
Thangapazham et al. [62] used both a cell system and an animal model to study the inhibitory effect of 
GT polyphenols, with an emphasis on EGCG, on human breast cancer cells. The phenol treatments 
resulted in down regulating cancer related genes and inhibiting cancer cell proliferation. Moreover, GT 
polyphenols and EGCG induced apoptosis in cancer cells of an athymic nude mice model. In another 
animal study, Henning et al. [63] xenotransplanted human prostate tumor into severe combined 
immunodeficiency (SCID) mice and then replaced water with brewed GT for 13 weeks. Tumor volume, 
oxidized DNA and protein damage in tumor tissue were all significantly reduced with GT consumption. 
Decreased expression of hypoxia-inducible factor 1-alpha, vascular endothelial growth factor and 
tumor 5-cytosine DNA methyltransferase 1 mRNA also occurred [63]. 
Other studies have focused on the general effect of GT beverage consumption on cancer prevention. 
Bettuzzi et al. [64] conducted a one-year double blind clinical trial on men with high-grade prostate 
intraepithelial neoplasia. Among the volunteers who were given catechins, only one tumor was 
diagnosed whereas nine cancers were detected among the placebo group. The catechin treated 
volunteers received significantly better scores on the international prostate symptom score and 
exhibited no significant side or adverse effects. However, in the 11 years of the previously discussed 
Ohsaki study, GT consumption did not correlate with decreased cancer related mortality [54]. 
Although research remains limited in human subjects, the combined (in vitro and in vivo) literature 
show the potential of GT to protect against oral, prostate, lung, colorectal cancer, and other target 
tissues. Such studies have been presented in several recently published reviews [65–67]. 
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Table 4. Recent studies on green tea and cancer.  
References Model Treatment Dosage Main outcomes 
Ohga et al. [57] 
Human cell lines 
A375SM and 
HSC3 
EGCG 100 μM 
EGCG selectively targeted 
tumor-associated endothelial 
cells and endothelial progenitor 
cells, thereby suppressing their 
migration.  
Kato et al. 
[58] 
Human cell lines 
HSC3, HSC4, 
SCC9, SCC25 and 
HeLa 
EGCG 5, 10, 20, 50 μM 
EGCG treatment partially 
reversed the hypermethylation 
status of the RECK gene. 
Siddiqui et al. 
[59] 
LNCaP and 22Rν1 
cells 
EGCG 
0, 10, 20, 40,  
60 μM 
EGCG competitively binding to 
AR and interrupting the gene 
expression regulated by AR. 
Yuasa et al. [61] 
Tissue of gastric 
cancer patients 
Brewed GT 0–10 cups per day 
Methylation of CDX2 and 
BMP-2 were inversely 
correlated with GT intake 
Thangapazham 
et al. [62] 
MDA-MB-231 cell 
line and athymic 
nude mice model 
EGCG and 
GTP 
0–200 μg/ml 
EGCG and GTP down regulated 
cancer related gene expression 
and inhibited proliferation of 
cancer cell. 
Henning et al. 
[63] 
Male SCID mice Brewed GT  
Tumor volume, oxidative DNA 
and protein damage in tumor 
tissue were all significantly 
reduced with GT consumption. 
Bettuzzi et al. 
[64] 
Men with high-
grade prostate 
intraepithelial 
neoplasia 
GT 
catechins 
600 mg/day 
One tumor was diagnosed in 
treatment group whereas nine 
cancers were detected among 
the placebo group. Treated 
group received higher score of 
international prostate symptom. 
Kuriyama et al. 
[54] 
Japanese adults Brewed GT 
<1, 1–2, 3–4, >5 
cups per day 
GT consumption did not 
significantly associate with 
cancer mortality. 
EGCG: (−)-epigallocatechin gallate; AR: androgen receptor; GTP: green tea phenols; GT: green tea. 
8. Gastrointestinal Health 
The human gastrointestinal (GI) tract contains more microorganisms than any other surface of the 
human body with the large intestine alone containing approximately 1014 microorganisms [68]. 
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Although remarkably constant within an individual over time, the microbiome can be perturbed by 
diseases or modulated by probiotic or prebiotic interventions [68–74]. Dietary polyphenols can also 
impact the GI microbiome by the time of absorption. Lee et al. [75] have provided extensive 
information on the gut microflora in response to GT extracts and their aromatic metabolites. The 
results showed that metabolites were produced by the bacteria after exposure to a GT polyphenol rich 
extract but their sensitivity towards polyphenols varied among species. The proliferation of “Good” 
bacteria (commensal anaerobes), which have been linked to benefits associated with host nutrition and 
health, were less affected by the extract but growth of pathogenic bacteria were significantly reduced. 
Su et al. [76] studied the effect of a commercial GT extract product containing 94% EGCG on three 
pathogenic bacteria (Staph. Aureus and Strep. Pyogenes), E. coli, and three probiotic bacteria  
(L. acidophilus, B. animalis and L. casei). The growth of all three pathogens was inhibited by GT at 
significantly lower levels (minimum inhibition concentration (MIC) of 100 μg/mL GT) compared to 
the three probiotic bacteria (MIC >800 μg/mL). Moreover, a synergistic effect between the probiotics 
and GT product was reported resulting in reduced growth of the pathogenic bacteria. The GT MIC 
value for E. coli was comparable to that of the probiotic bacteria. These results are consistent with a 
later study demonstrating that a GT extract inhibited probiotic bacteria and E. coli indiscriminately [77]. 
Alternatively, Molan et al. [78] compared two types of GT with different mineral composition. 
Exposure to a Chinese GT only slightly increased the growth of L. rhamnosus but had no effect on  
B. breve. However, the selenium-containing GT positively influenced the growth of both organisms 
indicating that the selenium content in GT could be a major factor in promoting probiotic  
bacterial growth. 
9. Bioavailability 
Research on the bioavailability of GT polyphenols is essential in order to understand their health 
promoting mechanisms. However, such studies have typically used cell models under certain digestion 
conditions while animal and human clinical trials remain limited. Nonetheless, Green et al. [79] 
conducted an in vitro digestive recovery experiment with EC, EGC, EGCG and ECG by subjecting 
each to a digestion protocol that mimicked the gastric and small intestinal environment. The results 
showed poor recovery of the pure catechins (<10%) after exposure to the digestion process. 
Conversely, a more recent study demonstrated that GT catechins are highly bioavailable [80]. In this 
study, plasma and urine samples were collected from ten healthy men before and after ingestion of  
500 mL GT beverage containing 648 μmol of flavan-3-ols over a 24 h period. A Cmax of 29~126 nM 
occurred in the plasma at 1.6~2.3 h (Tmax) post ingestion indicating that absorption occurred in the 
small intestine. Analysis of the urine samples showed 11.4% recovery of EGC and 28.5% of EC. The 
researchers also noted that accurate quantification of catechins bioavailability cannot be accessed 
solely by Cmax and Tmax values because flavan-3-ols metabolites rapidly circulate in the system.  
Roowi et al. [81] studied flavan-3-ols degradation in the large intestine by incubating GT-EC, EGC, 
and EGCG with human fecal samples. The results showed degradation of the flavan-3-ols  
at concentrations equivalent to 40% of the initial intake. A follow-up study completed by  
Calani et al. [82] identified GT flavan-3-ol metabolites in the urine of 20 volunteers. For the first time, 
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six colonic metabolites were recovered supporting the important role of colonic microbiota in the 
digestion of GT flavan-3-ol. The mean bioavailability was approximately 62% after 48 h.  
Green tea polyphenols bioavailability can be enhanced with food additives or by ingestion through 
different forms. By combining a catechin extract with food additives (ascorbic acid and sucrose),  
Peters et al. [83] showed increased catechin absorption (from 61.0 pmol·h/L plasma to 181.8 pmol·h/L 
plasma) using a digestion/Caco-2 cell model. Henning et al. [84] showed increased bioavailability  
of GT flavonoids in healthy humans when supplemented as a capsule. In yet another study,  
Chow et al. [85] determined the oral bioavailability of GT catechins using human volunteers randomly 
assigned to different dose groups and administered a catechin supplement in capsule form with or 
without a breakfast. Analyses of tea catechin levels in plasma and urine showed that bioavailability 
was greater under fasting conditions. 
GT phenols (either free, conjugated or bound) bioavailability is thus dependent upon the food 
vehicle (beverage or extract) or upon other foods consumed [86]. However, there also remains a 
critical lack of information on the interactions of GT catechins in the complex matrix in terms of their 
physicochemical properties [86]. Additionally, GT phenols, particularly the catechins, readily undergo 
biotransformation via methylation, glucuronidation, sulfation, and ring fission [87], which can affect 
their health benefiting properties, their site of absorption and multiple host related factors (e.g., gender, 
age, genetics, etc.) [88]. For more information on the bioavailability—biotransformation of phenolic 
based compounds, including the tea constituents, and their relationship to health, the reader is referred 
to other comprehensive reviews [36,86–88].  
10. Conclusions 
Evidence supporting the health benefits of GT intake, with an emphasis on the catechins, has been 
accumulating at an unprecedented rate over the past decade, including its ability to prevent or 
remediate inflammation, atherosclerosis, cancer, obesity and diabetes. The mechanisms by which GT 
may exert their effects have also been studied using different experimental designs and approaches. 
For example, it is widely agreed that phenols protect against cellular oxidative stress albeit no longer 
as free radical scavengers or chelators of redox metals but rather as cell signaling agents of 
endogenous responses. However, most GT antioxidative related research has been completed in vitro. 
Adding to the uncertainty of where and when GT polyphenols accumulate in or pass through the body, 
it is questionable that the same antioxidant effect in vitro will be similar to in vivo results. Moreover,  
in vivo studies are difficult if not impossible due to the current lack of methods to reliably measure 
ROS levels. By contrast, other studies have shown the GT pro-oxidant activity promotes endogenous 
antioxidant systems and thus increases antioxidant enzymes expression. Given that more evidence is 
available on the ability of GT polyphenols to modulate gene expression and cell signaling via animal 
and human studies, this mechanism may be more important in terms of preventing cancer, metabolic 
disorders, etc. However, more questions need to be answered: Where do GT polyphenols go? Do they 
stay, and for how long? How do other food matrices (such as caffeine, proteins, carbohydrates) affect 
the health promoting properties of GT? The choice of cell or animal models and how they relate to 
humans, dosages, introduction of other dietary agents and the analytical approach used should be 
carefully considered. Extensive meta-analysis of the existing data may aid in answering these 
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questions. Moreover, the effect of GT on the GI microbiome and vice versa cannot be ignored in the 
context of their seemingly symbiotic relationship. Lastly, GT catechins have received the major focus 
of study while other polyphenols have been largely neglected. However, as the emphasis of 
understanding synergisms among nutraceuticals is growing, it is expected that more studies will focus 
on the possible roles that GT polyphenols play in concert to protect against specific cellular stresses or 
diseases. Nonetheless, the current studies suggest that the GT agricultural base will continue to shift 
from one that produces a highly popular beverage to one that also includes GT as a potent health 
promoting food.  
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